Creative Details

Quality Score: 7/10

The advertisement promotes SKYRIZI, a prescription medication aimed at helping adults with moderate to severe Crohn's disease achieve remission, while also providing important safety information.

Creative Information

CID:e6d05443-ed7f-4f19-807e-62f30d669d15
CRID:25_p6b20hk6
Domain:skyrizi.com
Seat:TTD
Size:160x600
Bid:$0.81
Timestamp:12/11/2025, 3:41:52 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess12/11/2025, 3:45:05 PM7.01s
    adomain_analysissuccess12/11/2025, 3:49:15 PM5.00s
    adomain_capturesuccess12/11/2025, 3:49:10 PM0.18s
    ad_rendersuccess12/11/2025, 3:44:57 PM31.25s
    brand_mappingsuccess12/11/2025, 3:41:52 PM0.12s

    Analysis Results

    Ad Format: banner

    Brands: Skyrizi

    Sensitive:Pharmaceutical Products
    Size:160x600
    Data Transferred:1419.37 KB
    Render Time:8.00 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1440.54 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js530.55
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js227.08
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N1670579.3958515PMPRECISIONTHETR/B32752529.408337218;dc_ver=106.314;dc_eid=40004000;sz=160x600;u_sd=1;gdpr=0;nel=1;dvs1=1;dvs10=g5z7oir;dvs11=kargo;dvs12=dv-51005708;dvs13=tvtropes.org;dvs15=102;dvs16=p6b20hk6;dvs17=8744;dvs2=tvtropes.org%252fpmwiki%252fpmwiki.php%252fSeries%252fBetterCallSaul;dvs3=zguhk0w;dvs4=eiz222v;dvs6=472180f8-b83a-4742-85bf-adfc5a581f28;dvs7=vymzzj8;dvs8=1;dvs9=vymzzj8;dc_adk=2027040026;ord=8vz5sx;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D472180f8-b83a-4742-85bf-adfc5a581f28%26ag%3Dg5z7oir%26sfe%3D1b5df339%26sig%3DNjvPQ_fkQxCxua2cOcwqzMmpZvyPGS8C50yXWPd6lC4.%26crid%3Dp6b20hk6%26cf%3D7770553%26fq%3D0%26t%3D1%26td_s%3Dtvtropes.org%26rcats%3D7sp%26mste%3Dtvtropes.org%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D70%26agsa%3D%26wp%3D0.8051126%26rgz%3D12304%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D8744%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D7.580000000000041%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D2%26cc%3D2~KLUv_WMdqREMlAMFFwADoXhROUG4XFtUbk1Uji0qx2WK6uVyw6LhKYhnc9u6JOB3FwMl_mKFBACWFBFz1b0VETP9tX3YWJhVAn9W1EGEYxGTSlGSdPoyhikJi5fXlkK6IkcbSmNmZHpBW22kfYvpekLgjRz-upkVzGyIpJo9-94UTUn2pKt7UFeP8VLerv1aQnMn_NWVPD7DembJsmqPmz2br7rVaLyCRZX_2Bi-3P7urJbLCOTyJc1-6B8fi8ewPd8eubLIMSGY9Bo3h0i0vgajgvWSwB41ZvKqy6P2tzeDZFAwmBtUav-b_-LyP7Kscwi2XXbdTTTg8-unjYc85pB4hqMJj889GnP1edeDt-4MaCOPSJ0qC7vCvHw9sv_OErNcoNixjPfDeLVQWtbEn05aN_31wng9K--nBZ5li8romJHezYiwFaEBZMQtDEUF6HDjlICRqw7mdOq9D3H8yzK-07HO83Eu23Pv03fO03WO-7SiH1eubjywvOkCAQLjxAmrHJ4mVOKQATPV5MKJL-6Pl7LkCK4NK8syd-n7wbFl4abymsSn6G2vW3kwBkA97_3e1t103dc0LUc5pCLNbiphebelVmdSfJB08VoQJAYeIXUZvbl1sorHgYCyM09RxrB4gzwuIIIFnNCkw_Nc5_6sFUb8gKUgdxFPqxBVTrUTVTSJcsoP8sYFlpT39PySy-sI7zwOtJRnvXcz7yrz_BfGvcKtdT6rqru-AS7pRtaqVPxX8C9QjD8W5dJ93BPOyso_HS-ZhH_bhhqYcuMdMh1jcHDbI9l4ZkknDK6QIvW7Ga2SdSpAp90DBNdhjzLqB0qIH61W0AJZgYRZ7aQ0l8bflOK7KntcEU5BPQGPM2yhsLthTzurlvpaulfWk4sUWke4QAM7CHteS5M572noaEdCLzGaDIy_JS9a8NXL91IhRFeR44hyaF6_hRhNlh5VHKPx243Bi42-78EDMtbmGFldeRyACDc9nVgnpJoO%26dur%3D1~KLUv_WMFoCgkdAHNBQBjCB030MkMPhFcQIUlko7B_JORklMGvalJAJOc8RbA0W5eGJaWboA0nsFTLIPe1ESASWJ4DoC9upLnIoW0tOSkJWfLFp9Zd8x5Yn77hdf-De3uFE65MazU_v-5ZLVcShpW1IRUlCsTfXwBxpsAx19K2sn1lGlUtBf8iDACglypk_wHq1ErrA4gFeuyDxWLiAGXkx6Ff98o8GAIWU7mAWcXuL0GuJLE06VPSG2QFrV8aK4nwvQHmuyRAQ..%26durs%3DAQoGXr%26bdc%3D131%26uidd%3DKYb4MVohLwZFxEBtCBTCEq-4lm8kXpH5BTecXNUFzwKw7fWN%26testid%3Diavc1%2520%26car%3D553%26fpa%3D169%26pcm%3D3%26ict%3DCellularNetwork4G%26said%3D4e8954c9-3964-48a0-bc8d-74ed36291cc4%26auct%3D1%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=GTeK5c*PVB;gcsr=m;stc=1;chaa=1;sttr=36;prcl=s107.56
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/vKVxIeXH0QGTDDOwiqpaTKZp5NNzUAHYSL8enmE7PZA.js53.39
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://s0.2mdn.net/sadbundle/1549634677314903948/US-SKZG-250465-Display-160x600-px/b284491410ab413a763dd94ed5b9e752.jpg33.50
    https://s0.2mdn.net/sadbundle/1549634677314903948/US-SKZG-250465-Display-160x600-px/c241d2708605604480d5df5cd0a2d5c9.svg28.67
    https://fonts.gstatic.com/s/oswald/v57/TK3iWkUHHAIjg752GT8Gl-1PKw.woff227.79

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2